AlphaClone Alternative Alpha ETF
ALFA
Chicago Board Options Exchange- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- United States of America
- IPO Date
- May 31, 2012
- CIK
- 0001540305
- Similar Companies
- Business
- AlphaClone Alternative Alpha ETF (ALFA) is an exchange-traded fund that seeks to track the performance, before fees and expenses, of the AlphaClone Hedge Fund Masters Index (or Hedge Fund Long/Short Index) by investing in a portfolio of U.S. equities replicating the disclosed long positions of hedge funds, ranked by proprietary Clone Score methodology; it employs a rules-based approach with dynamic hedging between long-only and market-neutral strategies based on broad U.S. equity index price targets. The fund invests across diversified sectors in growth and value stocks spanning large-, mid-, and small-cap companies, primarily focused on U.S. total market equities with geographic concentration in North America. Launched on May 30, 2012, by ETF Series Solutions as part of a trust structure, it was managed by Exchange Traded Concepts, LLC as adviser and sub-advised by entities including Vident Investment Advisory and Index Management Solutions, with AlphaClone, Inc., a San Francisco-based registered investment adviser founded in 2008 and headquartered at 1 Market Street, serving as index provider. The ETF offers investors liquid, transparent exposure to hedge fund-like alpha strategies derived from public 13F disclosures, with an expense ratio of 0.65% and occasional distributions such as a 2020 dividend yield of 0.42%; it targeted institutional and retail investors seeking alternative equity replication without direct hedge fund access. In a significant operational change, ETF Series Solutions announced the termination of ALFA on August 16, 2022, with trading ceasing on August 30, 2022, and full liquidation on August 31, 2022, distributing $62.08262695 per share in cash to remaining shareholders; all related options were accelerated to expire September 16, 2022, and settled in cash. No recent partnerships, funding rounds, acquisitions, or new product launches involving ALFA or its direct affiliates have been reported post-liquidation, as the fund is no longer active and AlphaClone's ETF operations concluded without noted strategic expansions or reorganizations in the last 1-2 years.